Clearmind Medicine Inc. (CMND)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

6.58 on 9 Oct 2026

1 buy4 sales at will0 planned sales

Fiscal year 2025, ended 31 Oct 2025, as filed

Net income

$3.86M

Free cash flow

$4.73M

Return on equity

-323.4%

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
16 Jun 2026	HRT FINANCIAL LP 10% owner	Sold at will	$73.19K	21.4%
15 Jun 2026	HRT FINANCIAL LP 10% owner	Sold at will	$10.57K	3.0%
12 Jun 2026	HRT FINANCIAL LP 10% owner	Sold at will	$7.06K	1.9%
11 Jun 2026	HRT FINANCIAL LP 10% owner	Sold at will	$27.70K	10.9%
10 Jun 2026	HRT FINANCIAL LP 10% owner	Bought	$330.33K	opened

20out of 100

Profitability 0

Financial strength 23

Growth n/a

Insiders 45

Strongest on insiders (45), weakest on profitability (0). A score of the business, not of the price.

Last 12 months

Only here

Bought

$330.33K

1 buy, 1 buyer

Sold

$118.52K

4 sales

Planned sales

under a 10b5-1 plan